In the work of Kiyono et al. [132] TGF-β treatment induced the formation of GFP-LC3 puncta in human MDA-MB-231 mammary carcinoma cells and in mouse mammary carcinoma cell line, JygMC. This evidence concerns the gene TGFB1 and breast carcinoma.